Kimberly Fultz

This inventor holds 1 USPTO granted patent. Top assignee: Adarx Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimberly Fultz. Retrieved from https://idiyas.com/inventor/kimberly-fultz-61h1fsjt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kimberly Fultz: Innovator in Complement Factor B-Modulating Compositions

Introduction

Kimberly Fultz is a notable inventor recognized for her contributions to the field of pharmaceuticals. She has developed innovative solutions that address significant health challenges. Her work is particularly focused on complement factor B-modulating compositions, which have potential applications in various therapeutic areas.

Latest Patents

Kimberly holds 1 patent for her invention titled "Complement Factor B-Modulating Compositions and Methods of Use Thereof." This patent reflects her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Currently, Kimberly is employed at Adarx Pharmaceuticals, Inc., where she continues to push the boundaries of pharmaceutical research. Her role involves extensive research and development, contributing to the company's mission of creating innovative therapies.

Collaborations

Kimberly collaborates with Rui Zhu, a fellow researcher, to enhance the effectiveness of their projects. Their partnership exemplifies the importance of teamwork in scientific innovation.

Conclusion

Kimberly Fultz is a pioneering inventor whose work in complement factor B-modulating compositions showcases her dedication to advancing healthcare solutions. Her contributions are vital to the ongoing development of effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…